Elia Di Schiavi

Dr. Elia Di Schiavi

Department of Biology, Agriculture and Food Science, Institute of Biosciences and BioResources (IBBR), National Research Council (CNR), Naples, 80131, Italy
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
VCViviana Cordeddu
Viviana Cordeddu
Elia Di SchiaviElia Di Schiavi
Elia Di Schiavi
LPLen A Pennacchio
Len A Pennacchio
AMAvi Ma’ayan
Avi Ma’ayan
ASAnna Sarkozy
Anna Sarkozy
MTMarco Tartaglia
Marco Tartaglia
Marco Tartaglia and colleagues report the identification of mutations of SHOC2 in individuals with Noonan-like syndrome with loose anagen hair. The mutations cause aberrantly acquired N-myristoylation of SHOC2 resulting in aberrant targeting of SHOC2 to the plasma membrane. SHOC2 is believed to function as a scaffold linking RAS to downstream signal transducers. N-myristoylation is a common form of co-translational protein fatty acylation resulting from the attachment of myristate to a required N-terminal glycine residue1,2. We show that aberrantly acquired N-myristoylation of SHOC2, a leucine-rich repeat–containing protein that positively modulates RAS-MAPK signal flow3,4,5,6, underlies a clinically distinctive condition of the neuro-cardio-facial-cutaneous disorders family. Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721)7 shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. Expression of SHOC2S2G in vitro enhanced MAPK activation in a cell type–specific fashion. Induction of SHOC2S2G in Caenorhabditis elegans engendered protruding vulva, a neomorphic phenotype previously associated with aberrant signaling. These results document the first example of an acquired N-terminal lipid modification of a protein causing human disease.

1 March 2019 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
EPElena V. Polishchuk
Elena V. Polishchuk
AMAssunta Merolla
Assunta Merolla
JLJosef Lichtmannegger
Josef Lichtmannegger
ARAlessia Romano
Alessia Romano
AIAlessia Indrieri
Alessia Indrieri
RPRoman Polishchuk
Roman Polishchuk

1 June 2007 in Gene
Verified
Journal Article
Closed access
GEGiovanni Esposito
Giovanni Esposito
Elia Di SchiaviElia Di Schiavi
Elia Di Schiavi
CBCarmela Bergamasco
Carmela Bergamasco
PBPaolo Bazzicalupo
Paolo Bazzicalupo

1 February 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SMSimone Martinelli
Simone Martinelli
OKOliver H.F. Krumbach
Oliver H.F. Krumbach
FPFrancesca Pantaleoni
Francesca Pantaleoni
SCSimona Coppola
Simona Coppola
Ehsan AminEhsan Amin
Ehsan Amin
GMGhayda M. Mirzaa
Ghayda M. Mirzaa

4 April 2014 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
EFElisabetta Flex
Elisabetta Flex
MJMamta Jaiswal
Mamta Jaiswal
FPFrancesca Pantaleoni
Francesca Pantaleoni
SMSimone Martinelli
Simone Martinelli
MSMarion Strullu
Marion Strullu
MTMarco Tartaglia
Marco Tartaglia
RASopathies, a family of disorders characterized by cardiac defects, defective growth, facial dysmorphism, variable cognitive deficits and predisposition to certain malignancies, are caused by constitutional dysregulation of RAS signalling predominantly through the RAF/MEK/ERK (MAPK) cascade. We report on two germline mutations (p.Gly39dup and p.Val55Met) in RRAS, a gene encoding a small monomeric GTPase controlling cell adhesion, spreading and migration, underlying a rare (2 subjects among 504 individuals analysed) and variable phenotype with features partially overlapping Noonan syndrome, the most common RASopathy. We also identified somatic RRAS mutations (p.Gly39dup and p.Gln87Leu) in 2 of 110 cases of non-syndromic juvenile myelomonocytic leukaemia, a childhood myeloproliferative/myelodysplastic disease caused by upregulated RAS signalling, defining an atypical form of this haematological disorder rapidly progressing to acute myeloid leukaemia. Two of the three identified mutations affected known oncogenic hotspots of RAS genes and conferred variably enhanced RRAS function and stimulus-dependent MAPK activation. Expression of an RRAS mutant homolog in Caenorhabditis elegans enhanced RAS signalling and engendered protruding vulva, a phenotype previously linked to the RASopathy-causing SHOC2S2G mutant. Overall, these findings provide evidence of a functional link between RRAS and MAPK signalling and reveal an unpredicted role of enhanced RRAS function in human disease.

27 April 2021 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
PDF file
GAGiorgia Adamo
Giorgia Adamo
DFDavid Fierli
David Fierli
DRDaniele P. Romancino
Daniele P. Romancino
SPSabrina Picciotto
Sabrina Picciotto
MBMaria E. Barone
Maria E. Barone
ABAntonella Bongiovanni
Antonella Bongiovanni
Cellular, inter‐organismal and cross kingdom communication via extracellular vesicles (EVs) is intensively studied in basic science with high expectation for a large variety of bio‐technological applications. EVs intrinsically possess many attributes of a drug delivery vehicle. Beyond the implications for basic cell biology, academic and industrial interests in EVs have increased in the last few years. Microalgae constitute sustainable and renewable sources of bioactive compounds with a range of sectoral applications, including the formulation of health supplements, cosmetic products and food ingredients. Here we describe a newly discovered subtype of EVs derived from microalgae, which we named nanoalgosomes. We isolated these extracellular nano‐objects from cultures of microalgal strains, including the marine photosynthetic chlorophyte Tetraselmis chuii, using differential ultracentrifugation or tangential flow fractionation and focusing on the nanosized small EVs (sEVs). We explore different biochemical and physical properties and we show that nanoalgosomes are efficiently taken up by mammalian cell lines, confirming the cross kingdom communication potential of EVs. This is the first detailed description of such membranous nanovesicles from microalgae. With respect to EVs isolated from other organisms, nanoalgosomes present several advantages in that microalgae are a renewable and sustainable natural source, which could easily be scalable in terms of nanoalgosome production.